Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree
INTRODUCTION: As the prevalence and incidence of diabetes mellitus (DM) continue to rise, the costs of the diagnostic strategies used to detect it have gained importance. The aim of this study was to analyze the cost of DM diagnostic strategies in a hospital setting. METHODS: This cross-sectional st...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Van Yuzuncu Yil University, School of Medicine
2020-09-01
|
| Series: | Van Tıp Dergisi |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-67984 |
| _version_ | 1797430290857066496 |
|---|---|
| author | Emine Füsun Karaşahin Mustafa Necmi İlhan Jülıde Yıldırım Öcal Ömer Karaşahin |
| author_facet | Emine Füsun Karaşahin Mustafa Necmi İlhan Jülıde Yıldırım Öcal Ömer Karaşahin |
| author_sort | Emine Füsun Karaşahin |
| collection | DOAJ |
| description | INTRODUCTION: As the prevalence and incidence of diabetes mellitus (DM) continue to rise, the costs of the diagnostic strategies used to detect it have gained importance. The aim of this study was to analyze the cost of DM diagnostic strategies in a hospital setting. METHODS: This cross-sectional study included people over 18 years old with no previous DM diagnosis that presented to the internal medicine outpatient clinic for any reason and underwent serum glucose testing between December 1, 2012 and February 28, 2013. Decision tree analysis was used to calculate weighted costs of the various diagnostic methods. RESULTS: The study included 520 people. The prevalence of DM and pre-DM was 16.3% and 15.0%, respectively. During the study period, the total cost of all tests used was 2164.40 USD, the average cost per person was 4.14 USD, and the average cost per diagnosis was 25.46 USD. The most cost-effective strategy for the diagnosis of DM was FPG and HbA1c tests requested together, while strategies using FPG testing were most cost-effective for the diagnosis of non-DM. DISCUSSION AND CONCLUSION: The diagnostic strategies recommended in national and international guidelines are considerably less costly than many of the strategies used in our hospital. Costs could be lowered by ensuring physicians are aware of and implementing more cost-effective diagnostic strategies. |
| first_indexed | 2024-03-09T09:26:32Z |
| format | Article |
| id | doaj.art-eb97e9d50dd24df2a9c2aafd5714264f |
| institution | Directory Open Access Journal |
| issn | 2587-0351 |
| language | English |
| last_indexed | 2024-03-09T09:26:32Z |
| publishDate | 2020-09-01 |
| publisher | Van Yuzuncu Yil University, School of Medicine |
| record_format | Article |
| series | Van Tıp Dergisi |
| spelling | doaj.art-eb97e9d50dd24df2a9c2aafd5714264f2023-12-02T06:03:43ZengVan Yuzuncu Yil University, School of MedicineVan Tıp Dergisi2587-03512020-09-0127444044510.5505/vtd.2020.67984VTD-67984Cost analysis of the diagnostic strategies used for diabetes mellitus with decision treeEmine Füsun Karaşahin0Mustafa Necmi İlhan1Jülıde Yıldırım Öcal2Ömer Karaşahin3Erzurum Provincial Health DirectorateGazi University, Department Of Public Health, AnkaraTED University, Department Of Economics, AnkaraErzurum Regional Research And Training Hospital, Infectious Diseases And Clinical Microbiology, ErzurumINTRODUCTION: As the prevalence and incidence of diabetes mellitus (DM) continue to rise, the costs of the diagnostic strategies used to detect it have gained importance. The aim of this study was to analyze the cost of DM diagnostic strategies in a hospital setting. METHODS: This cross-sectional study included people over 18 years old with no previous DM diagnosis that presented to the internal medicine outpatient clinic for any reason and underwent serum glucose testing between December 1, 2012 and February 28, 2013. Decision tree analysis was used to calculate weighted costs of the various diagnostic methods. RESULTS: The study included 520 people. The prevalence of DM and pre-DM was 16.3% and 15.0%, respectively. During the study period, the total cost of all tests used was 2164.40 USD, the average cost per person was 4.14 USD, and the average cost per diagnosis was 25.46 USD. The most cost-effective strategy for the diagnosis of DM was FPG and HbA1c tests requested together, while strategies using FPG testing were most cost-effective for the diagnosis of non-DM. DISCUSSION AND CONCLUSION: The diagnostic strategies recommended in national and international guidelines are considerably less costly than many of the strategies used in our hospital. Costs could be lowered by ensuring physicians are aware of and implementing more cost-effective diagnostic strategies.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-67984costcost-effectivenessdecision treediabetes mellitusdiagnosis |
| spellingShingle | Emine Füsun Karaşahin Mustafa Necmi İlhan Jülıde Yıldırım Öcal Ömer Karaşahin Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree Van Tıp Dergisi cost cost-effectiveness decision tree diabetes mellitus diagnosis |
| title | Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree |
| title_full | Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree |
| title_fullStr | Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree |
| title_full_unstemmed | Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree |
| title_short | Cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree |
| title_sort | cost analysis of the diagnostic strategies used for diabetes mellitus with decision tree |
| topic | cost cost-effectiveness decision tree diabetes mellitus diagnosis |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-67984 |
| work_keys_str_mv | AT eminefusunkarasahin costanalysisofthediagnosticstrategiesusedfordiabetesmellituswithdecisiontree AT mustafanecmiilhan costanalysisofthediagnosticstrategiesusedfordiabetesmellituswithdecisiontree AT julıdeyıldırımocal costanalysisofthediagnosticstrategiesusedfordiabetesmellituswithdecisiontree AT omerkarasahin costanalysisofthediagnosticstrategiesusedfordiabetesmellituswithdecisiontree |